TV-45070

DRUG3 trials

Sponsors

Teva Branded Pharmaceutical Products R&D, Inc.

Conditions

Osteoarthritis of the KneePharmacokineticsPostherpetic Neuralgia

Phase 1

Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy Volunteers

CompletedNCT02215941

Teva Branded Pharmaceutical Products R&D, Inc.Pharmacokinetics

Start: 2014-08-31End: 2015-02-28Updated: 2021-11-09

Phase 2

A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (Ointment) in Participants With Primary Osteoarthritis (OA) Affecting a Single Knee

CompletedNCT02068599

Teva Branded Pharmaceutical Products R&D, Inc.Osteoarthritis of the Knee

Start: 2014-04-14End: 2015-05-04Updated: 2021-11-09

A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpetic Neuralgia (PHN)

CompletedNCT02365636

Teva Branded Pharmaceutical Products R&D, Inc.Postherpetic Neuralgia

Start: 2015-02-26End: 2017-05-09Updated: 2021-11-09